Clover Health Investments, Corp.

CLOV Healthcare Healthcare Plans

Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.

Revenue
+52.9%
EPS
+350.0%
Free cash flow
+508.9%

Quarter to September 2026, against a year earlier

4.82 0.34 +7.59%
Market cap
$2.4B
P/E
0.0×
Fwd P/E
87.4×
Dividend yield
—
F-score
3/9
Altman Z
0.44
Beneish M
−1.72
Dividend safety
n/a

Clover Health Investments, Corp. (CLOV) P/S ratio

Alert me on P/S ratio

As of 6 November 2026, Clover Health Investments, Corp. (CLOV) trades at a P/S ratio of 0.9×. Over the past ten years it has ranged from 0.0× (December 2023) to 42.5× (August 2023); the current reading is higher than 60% of that period. That is above the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.6× (44.47%)
FY2024 1.1× 206.59%
FY2023 0.4× (11.00%)
FY2022 0.4× (60.46%)
FY2021 1.0× (52.79%)
FY2020 2.2× —
FY2019 0.0× —

Quarterly newest first

Period P/S ratio Change
Sep 2026 0.8× (24.58%)
Jun 2026 1.1× 166.84%
Mar 2026 0.4× (33.53%)
Dec 2025 0.6× (29.33%)
23 more quarters

Against its own ten years

Low 0.0× High 42.5×
Ten-year median 0.8×
Current reading's percentile 54

P/S ratio against peers

Company P/S ratio
CNC Centene Corporation compare 0.2×
MOH Molina Healthcare, Inc compare 0.2×
CI Cigna Group compare 0.3×
ALHC Alignment Healthcare, Inc. compare 0.3×
HUM Humana Inc. compare 0.3×
ELV Elevance Health, Inc. compare 0.5×
OSCR Oscar Health, Inc. compare 0.5×
CLOV Clover Health Investments, Corp. 0.9×
PGNY Progyny, Inc. compare 2.0×
Healthcare Plans industry median 0.4×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on CLOV